Abbott Sees FY Adjusted EPS of $5.50-$5.55
Story updates
11:31:57 AM UTC
SquawkNews
Abbott Laboratories (NYSE: ABT ) narrows FY2026 Adj EPS guidance from $5.45-$5.60 to $5.50-$5.55 vs $5.52 analyst estimate..
Related stories
ABN AMRO Q3 26 Earnings
Net Profit: 939M Oper Income: 2.64B Net Interest Income: 1.82B (est 1.78B) CET1 Ratio: 15.3% (est 15.4%) Sees FY Costs: 5.5B, Saw Around 5.5B (est 5.41B) Sees FY Commercial Net Int
H impact | EARNINGS | Nov 11, 2026, 06:23 AM UTC
Siemens Energy Q4 Free Cash Flow Reaches €1,636 Million
M impact | EARNINGS | Nov 11, 2026, 06:07 AM UTC
Siemens Energy reports Q4 net income of EUR 1,360 million
M impact | EARNINGS | Nov 11, 2026, 06:07 AM UTC
Siemens Energy Q4 FY26 Net Income Rises to €1.36 Billion
M impact | EARNINGS | Nov 11, 2026, 06:05 AM UTC
Suntory Beverage & Food 9-Month Results Rise; Cuts Annual Net Profit Outlook On Inflation
TOKYO (dpa-AFX) - Suntory Beverage & Food Limited (STBFY, STBFF, 2587.T), a Japanese maker of non-alcoholic beverages and food products, on Wednesday recorded a rise in earnings an
L impact | EARNINGS | Nov 11, 2026, 06:04 AM UTC
SOFTWAREONE HOLDING AG - FY 2026 OUTLOOK ON ADJUSTED EBITDA MARGIN RAISED FROM ABOVE 23% TO ABOVE 24%
L impact | EARNINGS | Nov 11, 2026, 06:03 AM UTC